R
Ronnier J. Aviles
Researcher at Cleveland Clinic
Publications - 23
Citations - 5195
Ronnier J. Aviles is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Myocardial infarction & Coronary artery disease. The author has an hindex of 16, co-authored 23 publications receiving 4949 citations. Previous affiliations of Ronnier J. Aviles include National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Inflammation as a risk factor for atrial fibrillation
Ronnier J. Aviles,David O. Martin,Carolyn Apperson-Hansen,Penny L. Houghtaling,Pentti M. Rautaharju,Richard A. Kronmal,Russell P. Tracy,David R. Van Wagoner,Bruce M. Psaty,Michael S. Lauer,Mina K. Chung +10 more
TL;DR: CRP is not only associated with the presence of AF but may also predict patients at increased risk for future development of AF.
Journal ArticleDOI
Prognostic Value of Myeloperoxidase in Patients with Chest Pain
Marie Luise Brennan,Marc S. Penn,Frederick Van Lente,Vijay Nambi,Mehdi H. Shishehbor,Ronnier J. Aviles,Marlene Goormastic,Michael Pepoy,Ellen McErlean,Eric J. Topol,Steven E. Nissen,Stanley L. Hazen +11 more
TL;DR: Myeloperoxidase levels, in contrast to troponin T, creatine kinase MB isoform, and C-reactive protein levels, identified patients at risk for cardiac events in the absence of myocardial necrosis, highlighting its potential usefulness for risk stratification among patients who present with chest pain.
Journal ArticleDOI
Association between myeloperoxidase levels and risk of coronary artery disease.
Renliang Zhang,Marie Luise Brennan,Xiaoming Fu,Ronnier J. Aviles,Gregory L. Pearce,Marc S. Penn,Eric J. Topol,Dennis L. Sprecher,Stanley L. Hazen +8 more
TL;DR: Elevated levels of leukocyte- and blood-MPO are associated with the presence of CAD, and a potential role for MPO as an inflammatory marker in CAD is supported and may have implications for atherosclerosis diagnosis and risk assessment.
Journal ArticleDOI
Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy.
Mehdi H. Shishehbor,Ronnier J. Aviles,Marie Luise Brennan,Xiaoming Fu,Marlene Goormastic,Gregory L. Pearce,Noyan Gokce,John F. Keaney,Marc S. Penn,Dennis L. Sprecher,Joseph A. Vita,Stanley L. Hazen +11 more
TL;DR: A preliminary study indicates that nitrotyrosine levels are associated with the presence of CAD and appear to be modulated by statin therapy, which suggests a potential role for nitric oxide-derived oxidants as inflammatory mediators in CAD and may have implications for atherosclerosis risk assessment and monitoring of anti-inflammatory actions of statins.
Journal ArticleDOI
Statins Promote Potent Systemic Antioxidant Effects Through Specific Inflammatory Pathways
Mehdi H. Shishehbor,Marie Luise Brennan,Ronnier J. Aviles,Xiaoming Fu,Marc S. Penn,Dennis L. Sprecher,Stanley L. Hazen +6 more
TL;DR: The present results suggest potential mechanisms that may contribute to the beneficial actions of statins and have important implications for monitoring the antiinflammatory and antioxidant actions of these agents.